Healthy Volunteers Needed for Oral Study Drug for Certain Types of Cancer
The Pfizer Clinical Research Unit is conducting a clinical trial with healthy volunteers to assess different forms of and the effect of food on an oral study drug for certain types of cancer. The study drug is being evaluated for the treatment of specific cancers, including small cell lung cancer, prostate cancer, and lymphoma. Millions of people are diagnosed with these cancers every year. Affected patients are in need of effective and safe treatments, and healthy volunteers are an important part of developing these medicines.
If you choose to participate, you will stay at our facility for 13 consecutive overnights. You will be placed in one of two groups and receive one of the following:
- Starting the morning after admission, you will receive a single oral dose of the study drug every 5 days as 3 different oral formulations, for a total of up to 3 doses.
- Starting the morning after admission, you will receive a single oral dose of the study drug while fasted, with a low-fat meal, or with a high-fat meal, for a total of up to 3 doses.
You will receive one each of the above doses at least 7 days apart, given on an empty stomach and in a randomly chosen order, for a total of 3 dosing periods.
Throughout the study, staff will closely monitor your health status and collect data, such as the levels of the study drug in your blood.
Up to $4,600 upon completion of the study
This study is seeking healthy adult volunteers, meaning that the participants will not have the condition being studied and are in overall good health. In addition to the criteria listed, participants must meet the following requirements:
- Willing to take a study drug
- Willing and able to come to our facility in New Haven, CT*
- Able to comply with all study procedures and appointments
- 18+ years
*participants may be eligible to receive a bonus for travel, ask our staff for details
There are other requirements for participation in this study. The study staff will explain these to you during the screening process.